FDA Approves Trodelvy® in Pre-treated HR+/HER2- Metastatic Breast Cancer

Click here to review the data.

Please see full Prescribing Information including BOXED WARNING.

TRODELVY-123x50
Gilead-125x50

Upcoming Events

Virtual Oncology Reimbursement Meeting (ORM) | Winter 2026

Virtual Oncology Reimbursement Meeting (ORM) | Winter 2026

Virtual December 9, 2026 at 11:00 AM EST
2027 ACCC Leadership Summit

2027 ACCC Leadership Summit

In Person April 22, 2027 at 6:00 PM EDTWillard InterContinental Hotel, 1401 Pennsylvania Avenue Northwest, Washington, DC, USAWashington